Intercept Pharmaceuticals | Creditori Commerciali



Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 36.71M 8M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Galectin Therapeutics USD 3.7M 99K 2024-06
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.56B 49M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12


Intercept Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.